Sarcoma Panel
Use
This test is designed for individuals who have a clinical or suspected diagnosis of hereditary sarcoma. It might be indicated for those with a personal or family history of sarcoma diagnosed at a young age, or with sarcoma and other related cancers that suggest a hereditary cancer syndrome. This panel can help in identifying genetic mutations associated with sarcoma, aiding in diagnosis and management of the disease.
Special Instructions
Not provided.
Limitations
The test's accuracy might be limited by factors such as the quality of the specimen, and the presence of certain types of mutations that may not be detectable by this method. It may not identify mutations outside the targeted regions of the 35 genes included in the panel.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided